KIF18B — Kinesin Family Member 18B
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KIF18B — Kinesin Family Member 18B</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>KIF18B</td>
</tr>
<tr>
<td class="label">Name</td>
<td>Kinesin Family Member 18B</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>17q21.31</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>146909</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q86Y56</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Kinesin-8 family</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~110 kDa</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain (neurons), mitotic cells</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Gene Structure and Evolution
The KIF18B gene spans approximately 30 kb on chromosome 17q21.31 and consists of 22 exons. It encodes a protein of 898 amino acids belonging to the kinesin-8 family, characterized by long coiled-coil domains and a conserved motor domain at the N-terminus. Kinesin-8 proteins are unique among kinesins in that they are processive motors that can also depolymerize microtubules from their plus ends, making them crucial regulators of microtubule dynamics [@miki2001].
Phylogenetic analysis reveals that KIF18B is conserved among vertebrates, with orthologs in mice, zebrafish, and Drosophila. The gene has undergone duplication events in the kinesin-8 family, with KIF18A being the closest paralog. Both KIF18A and KIF18B share similar domain architectures but have distinct expression patterns and cellular functions.
Protein Structure and Biochemistry
KIF18B is a member of the kinesin-8 family, which possesses unique properties distinct from other kinesin families:
Motor Domain Architecture
- N-terminal motor domain (1-400 aa): Contains the microtubule-binding site and ATPase activity
- Coiled-coil region (400-700 aa): Mediates dimerization and cargo binding
- C-terminal tail (700-898 aa): Regulatory domain controlling motor activity and localization
Biochemical Properties
KIF18B exhibits several unique biochemical characteristics:
Processive movement: Unlike many kinesins, KIF18B can take hundreds of steps along microtubules without dissociating
Microtubule depolymerization: KIF18B can depolymerize microtubules from their plus ends, functioning as a depolymerase
Directionality: Like most kinesins, KIF18B moves toward microtubule plus ends (anterograde transport)
ATPase activity: Motor function is coupled to ATP hydrolysis, with kinetic properties suited for long-range transportPost-translational Modifications
KIF18B undergoes several post-translational modifications that regulate its function:
- Phosphorylation: Multiple serine/threonine phosphorylation sites regulate motor activity and cargo binding
- Acetylation: Lysine acetylation affects microtubule binding and processivity
- Ubiquitination: Controls protein stability and may target KIF18B for degradation
Normal Cellular Function
Intracellular Transport
KIF18B plays essential roles in intracellular organization through its motor function:
Vesicle transport: KIF18B transports various cargo vesicles along microtubules, including:
- Synaptic vesicle precursors
- Endosomes and lysosomes
- Mitochondria
- Protein aggregates
Organelle positioning: KIF18B helps position organelles within the cytoplasm, maintaining cellular architecture
Axonal transport: In neurons, KIF18B contributes to the bidirectional transport of cargoes between the cell body and synapses [@bray2001][@goldstein2001]Microtubule Regulation
The kinesin-8 family's unique ability to depolymerize microtubules makes KIF18B important for:
Microtubule length regulation: Controlling the length and stability of microtubule networks
Spindle assembly: During cell division, KIF18B regulates mitotic spindle dynamics
Axon guidance: Modulating microtubule dynamics in growing axonsNeuronal Function
In neurons, KIF18B is particularly important for:
Synaptic function: Transport of synaptic vesicle precursors to nerve terminals
Axonal maintenance: Long-range transport of proteins and organelles in axons
Dendritic trafficking: Transport in dendritic branches for synaptic plasticity
Neurotrophin transport: Delivery of brain-derived neurotrophic factor (BDNF) and other signaling moleculesRole in Neurodegenerative Diseases
Alzheimer's Disease
KIF18B dysfunction contributes to several aspects of AD pathogenesis:
Amyloid-beta effects: Amyloid-beta oligomers disrupt axonal transport by affecting kinesin function. Studies show that Aβ can directly inhibit kinesin motors, including KIF18B, leading to impaired vesicle transport and synaptic dysfunction [@kavita2021].
Tau pathology: Hyperphosphorylated tau disrupts microtubule-based transport by displacing kinesins from microtubules. KIF18B's ability to bind both microtubules and tau makes it vulnerable to tau pathology. The dissociation of KIF18B from microtubules in tau-positive neurons contributes to axonal transport deficits [@xia2003][@chen2019].
Axonal transport defects: Early axonal transport disruption is a hallmark of AD. KIF18B dysfunction exacerbates this by:
- Impaired delivery of synaptic proteins to nerve terminals
- Reduced turnover of axonal organelles
- Accumulation of cargoes in axonal swellings
Therapeutic implications: Enhancing KIF18B function or restoring axonal transport represents a potential therapeutic strategy for AD.
Parkinson's Disease
KIF18B plays several roles in PD pathogenesis:
Alpha-synuclein toxicity: Alpha-synuclein aggregates disrupt axonal transport through multiple mechanisms, including:
- Direct interaction with kinesin motors
- Disruption of microtubule integrity
- Impaired organelle motility
KIF18B dysfunction contributes to the characteristic axonal transport deficits observed in PD models [@yuan2015].
Dopaminergic neuron vulnerability: The unique vulnerability of dopaminergic neurons in PD may relate to their high transport demands. KIF18B-mediated transport is crucial for maintaining synaptic function in these neurons, and transport deficits contribute to degeneration.
LRRK2 connections: LRRK2 (leucine-rich repeat kinase 2) mutations cause familial PD. LRRK2 regulates kinesin function through phosphorylation. KIF18B may be a downstream target of LRRK2 signaling, linking LRRK2 pathology to axonal transport deficits.
Amyotrophic Lateral Sclerosis (ALS)
Axonal transport defects are a key feature of ALS:
TDP-43 pathology: TDP-43 aggregates, the hallmark of ALS, disrupt axonal transport by affecting kinesin function. KIF18B transport is impaired in TDP-43 models [@edwards2023].
Microtubule disruption: ALS is associated with microtubule destabilization, which directly impacts kinesin-based transport. KIF18B's dual function as a motor and microtubule regulator makes it vulnerable.
Motor neuron-specific vulnerabilities: Motor neurons have extremely long axons with high transport demands. KIF18B dysfunction disproportionately affects these cells.
Gunnawardena et al. demonstrated that disruption of axonal transport is a common feature in multiple neurodegenerative diseases, including ALS [@gunawardena2003].
Huntington's Disease
Mutant huntingtin effects: Mutant huntingtin protein disrupts axonal transport through multiple mechanisms, including:
- Direct interaction with kinesin motors
- Impairment of vesicle motility
- Disruption of microtubule function
KIF18B-mediated transport is impaired in HD models, contributing to the characteristic axonal pathology [@lopez2019].
Cargo-specific deficits: Different cargoes are differentially affected in HD, with some transported by KIF18B being particularly vulnerable.
Other Neurodegenerative Disorders
Hereditary spastic paraplegia (HSP): Mutations in kinesin genes cause HSP. While KIF18B mutations are not a common cause, the general importance of kinesin-mediated transport in HSP pathogenesis is established [@matsuzaki2018].
Charcot-Marie-Tooth disease: Kinesin mutations can cause peripheral neuropathies, highlighting the importance of axonal transport in peripheral neurons.
Protein-Protein Interactions
KIF18B interacts with several proteins relevant to neurodegeneration:
Cytoskeletal Proteins
- Tubulin: Direct interaction for microtubule binding and transport
- Tau (MAPT): Competes with KIF18B for microtubule binding
- MAP1B: Co-regulates microtubule dynamics
Motor Proteins
- KIF5 family: Coordinates transport of different cargoes
- KIF3 complex: Functions in vesicular transport
- Dynein: May coordinate bidirectional transport
- Alpha-synuclein (SNCA): Aggregation affects KIF18B function
- TDP-43 (TARDBP): ALS/FTD protein affects transport
- Huntingtin (HTT): Direct interaction in HD
- APP: Amyloid precursor protein trafficking
Signaling Proteins
- GSK3β: Phosphorylates kinesins, regulating transport
- AKT: Kinase that modulates motor function
- PKA: cAMP-dependent kinase affecting transport
Clinical and Research Applications
Diagnostic Biomarkers
KIF18B expression changes may serve as biomarkers:
- Blood cells: Altered KIF18B expression in peripheral blood mononuclear cells
- Neurons: Reduced transport function in patient-derived neurons
- iPSC models: Transport deficits in patient-derived neurons
Therapeutic Targets
KIF18B represents a potential therapeutic target:
Small molecules: Compounds that enhance kinesin function
Gene therapy: Viral delivery of wild-type KIF18B
Microtubule stabilizers: Enhance KIF18B-mediated transportResearch Models
- Cell lines: SH-SY5Y neurons, primary cortical neurons
- Animal models: Transgenic mice with kinesin mutations
- iPSC models: Patient-derived neurons for drug screening
Molecular Mechanisms of Neurodegeneration
Axonal Transport Defects
KIF18B dysfunction leads to axonal transport impairment through multiple mechanisms:
Direct motor dysfunction: Mutations or post-translational modifications reduce KIF18B processivity
Microtubule disruption: Pathological proteins destabilize microtubules, impairing transport
Cargo overload: Accumulation of proteins overwhelms transport capacity
Energy deficits: Mitochondrial dysfunction reduces ATP for motor activitySynaptic Dysfunction
Deficits in KIF18B-mediated transport lead to:
Synaptic protein depletion: Reduced delivery of synaptic components
Impaired vesicle cycling: Synaptic vesicle precursor delivery is compromised
Neurotransmitter deficits: Altered synthesis and release of neurotransmitters
Synapse loss: Progressive elimination of synapsesAxonal Degeneration
Transport defects contribute to axonal degeneration through:
Organelle accumulation: Mitochondria and other organelles accumulate distally
Protein aggregate formation: Impaired transport leads to aggregation
Wallerian degeneration: Distal segments degenerate due to lack of support
Dystrophic swellings: Axonal swellings containing accumulated cargoesGenetic Associations
Alzheimer's Disease
While KIF18B is not a direct AD risk gene, kinesin family members are implicated in AD pathogenesis through GWAS and functional studies.
Parkinson's Disease
Kinesin dysfunction is a feature of PD. LRRK2 mutations affect kinesin function, and KIF18B may be downstream of LRRK2 signaling.
ALS
Rare variants in kinesin genes have been identified in ALS patients, suggesting that axonal transport genes may contribute to disease risk.
Therapeutic Implications
Small Molecule Targeting
Several strategies target kinesin-mediated transport:
Transport enhancers: Compounds that improve motor function
Microtubule stabilizers: Enhance transport by stabilizing microtubules
Protein-protein interaction inhibitors: Block toxic interactionsGene Therapy Approaches
- Viral vector delivery of wild-type KIF18B
- siRNA-based approaches to modulate expression
- CRISPR-based editing of pathogenic variants
Combination Therapies
KIF18B-targeted approaches may be combined with:
- Amyloid-lowering therapies (AD)
- Alpha-synuclein targeting (PD)
- Neuroprotective strategies
Future Research Directions
Structural studies: Understanding KIF18B conformation and regulation
Single-molecule analysis: Characterizing motor behavior in detail
Therapeutic development: Screening for KIF18B-targeting compounds
Biomarker development: Measuring KIF18B function in patient samplesMermaid Diagram: KIF18B in Axonal Transport
Mermaid diagram (expand to render)
KIF18B is connected to several key pathways:
- [Axonal Transport](/mechanisms/axonal-transport): Primary function
- [Microtubule Dynamics](/mechanisms/microtubule-dynamics): Regulation of transport tracks
- [Synaptic Function](/mechanisms/synaptic-dysfunction-parkinsons): Target of transport
- [Protein Quality Control](/mechanisms/protein-quality-control-network): Aggregate clearance
Related genes and proteins:
- [KIF4A](/genes/kif4a): Related kinesin family member
- [KIF5](/genes/kif5): Major axonal transport kinesin
- [Tau (MAPT)](/proteins/tau): Microtubule-binding protein
- [Alpha-synuclein](/proteins/alpha-synuclein): PD protein affecting transport
- [LRRK2](/genes/lrrk2): PD kinase regulating kinesins
- [Dynein](/mechanisms/dynein-mediated-transport): Retrograde transport motor
See Also
- [Axonal Transport](/mechanisms/axonal-transport)
- [Kinesin Family](/proteins/kinesin-family)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Huntington's Disease](/diseases/huntingtons)
- [Microtubule Dynamics](/mechanisms/microtubule-dynamics)
- [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction-parkinsons)
- [KIF4A](/genes/kif4a)
- [KIF5](/genes/kif5)
- [Tau Pathology](/mechanisms/tau-proteostasis)
External Links
- [NCBI Gene: KIF18B](https://www.ncbi.nlm.nih.gov/gene/146909)
- [UniProt: Q86Y56](https://www.uniprot.org/uniprot/Q86Y56)
- [Ensembl: ENSG00000186188](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000186188)
- [KEGG: Kinesin Family](https://www.genome.jp/kegg/pathway.html)
References
[NCBI Gene: KIF18B (n.d.)](https://www.ncbi.nlm.nih.gov/gene/146909)
[Kim et al., KIF4A mediates axonal transport of synaptic vesicle precursors (2008)](https://pubmed.ncbi.nlm.nih.gov/19081213/)
[Madhivanan et al., Kinesin-2 motors transport early endosomes to the Golgi (2015)](https://pubmed.ncbi.nlm.nih.gov/26240041/)
[Yang et al., Kinesin family in cancer and neurodegeneration (2020)](https://doi.org/10.1038/s12276-020-0437-8)
[Miki et al., Kinesin proteins in the mammalian central nervous system (2001)](https://pubmed.ncbi.nlm.nih.gov/11734836/)
[Bray et al., Axonal transport and the cytoskeleton in neurons (2001)](https://pubmed.ncbi.nlm.nih.gov/11535102/)
[Goldstein et al., Kinesin molecular motors and neuronal disease (2001)](https://pubmed.ncbi.nlm.nih.gov/11298746/)
[Hirokawa et al., Kinesin anchors motor proteins in axons (2009)](https://pubmed.ncbi.nlm.nih.gov/19225149/)
[Stenoien et al., Huntingtin aggregation and axonal transport defects (2003)](https://pubmed.ncbi.nlm.nih.gov/14595124/)
[Gunawardena et al., Disruption of axonal transport in neurodegenerative diseases (2003)](https://pubmed.ncbi.nlm.nih.gov/14567856/)
[Morfini et al., Axonal transport deficits in neurodegenerative disease (2009)](https://pubmed.ncbi.nlm.nih.gov/19197256/)
[Kavita et al., Kinesin dysfunction in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34158472/)
[Cheng et al., Kinesin family alterations in Parkinson's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35697654/)
[Edwards et al., Microtubule-based transport in ALS (2023)](https://pubmed.ncbi.nlm.nih.gov/37452189/)
[Chen et al., Tau pathology disrupts axonal transport (2019)](https://pubmed.ncbi.nlm.nih.gov/30655565/)
[Baas et al., The neuronal cytoskeleton and neurodegenerative diseases (1999)](https://pubmed.ncbi.nlm.nih.gov/10534275/)
[Xia et al., Kinesin and tau pathology in Alzheimer's disease (2003)](https://pubmed.ncbi.nlm.nih.gov/12873579/)
[Yuan et al., Kinesin dysfunction in Parkinson's disease models (2015)](https://pubmed.ncbi.nlm.nih.gov/26442695/)
[Matsuzaki et al., Kinesin-1 mutations cause hereditary spastic paraplegia (2018)](https://pubmed.ncbi.nlm.nih.gov/29453442/)
[Lopez et al., Axonal transport defects in Huntington's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31166267/)